ESKETAMINE TREATMENT

Discover SPRAVATO®

New Hope for Treatment-Resistant Depression

ABOUT ESKETAMINE

What is SPRAVATO®?

SPRAVATO® (esketamine) is a safe, non-invasive prescription nasal spray designed to treat adults with major depressive disorder (MDD) who have not found relief with other antidepressant treatments. Unlike traditional antidepressants, SPRAVATO® can work quickly, sometimes within hours or days, offering a new avenue of hope for those struggling with treatment-resistant depression.

How Does SPRAVATO® Work?

SPRAVATO® contains esketamine, a derivative of ketamine, which targets the NMDA receptor in the brain. This mechanism is believed to help restore synaptic connections in brain cells involved in mood regulation. By acting on a different pathway than conventional antidepressants, SPRAVATO® provides rapid relief and can improve symptoms where other treatments have failed.

Inquire Now

Please fill out this form and we’ll be in touch.

Disclaimer: Acacia Clinics is collecting this information so we can send you details for the study you’re interested in.

Why Choose SPRAVATO®?

Rapid Onset of Action: SPRAVATO® can reduce depressive symptoms, sometimes within hours to days.

For Treatment-Resistant Depression: Specifically developed for adults who haven't responded to at least two different antidepressants.

Convenient Administration: Self-administered nasal spray under the supervision of a healthcare professional.

What to Expect

Initial Consultation: Our doctors will assess your condition and determine if SPRAVATO® is right for you.

First Dose: Administered in our clinic, where you'll be monitored for about two hours.

Ongoing Treatment: Regular follow-up visits ensure safety and efficacy, with most patients continuing treatment twice a week for the first month, then weekly or every two weeks thereafter.

ACACIA’S VALUES

Our Commitment to Patients

We are committed to helping our patients find a treatment that works. Though we have had great success with conventional and accelerated TMS therapy, there still are some patients who do not respond to TMS. We’ve chosen to add SPRAVATO® to our offerings to provide another pathway to wellness and healing.

It is part of Acacia's commitment to stay on the cutting-edge towards innovation and evidence-based treatments with a scientific foundation.

Payment Options

Covering treatment costs can be an obstacle for many patients, so we offer several ways to pay for TMS therapy services.

We believe everyone should have access to better mental health treatment. Acacia’s staff also works with employers, insurance companies, and government officials to make these proven treatments more widely accessible.

Insurance Plans

TMS is covered by most insurance providers for depression. Acacia accepts most insurance plans and will work with you to determine if you are eligible.

Private Pay

Acacia has private pay options for all of our services, including TMS and Accelerated TMS. Please contact us to discuss our fees. Acacia accepts cash, check, and all major credit cards.

Financial Aid

Acacia is pleased to provide financial aid for those who would benefit from TMS but may not be eligible for insurance coverage, or do not have insurance. Please contact us for more information.

ACCEPTED INSURANCES

Standard TMS Therapy is covered by most insurance companies. If your insurance provider is not presently covering TMS, Acacia can help you negotiate with your insurance provider for reimbursement, on a case-by-case basis.

Safety and Side Effects

As with any medication, SPRAVATO® comes with potential side effects, including dizziness, nausea, and dissociation. Your healthcare provider will monitor you closely to manage any adverse effects. It is important to only use SPRAVATO® under the supervision of a certified medical professional to ensure safety.This study involves two in-person sessions, follow-up surveys or phone calls, and two onsite follow-up visits. The in-person sessions will take place at the study site and involves ultrasound, questionnaires, and wearing a brain activity-measuring device.

START YOUR JOURNEY

Embark on Your Journey to Better Mental Health

If you or a loved one is struggling with treatment-resistant depression, SPRAVATO® might be the breakthrough you've been waiting for. Contact us today to learn more about how SPRAVATO® can be part of your path to recovery.

FAQ

  • Clinical studies have shown that Spravato can significantly reduce symptoms of depression. Many patients experience improvement within the first 24 hours, and the benefits can continue with ongoing treatment.

  • Patients have reported significant improvement in their depressive symptoms as early as the first week of treatment with Spravato.

  • Spravato has been approved by the FDA and has undergone extensive clinical trials to evaluate its safety and efficacy. However, like all medications, it may have side effects. Common side effects include dizziness, dissociation, nausea, and headache. It's important to discuss potential risks with your healthcare provider.

  • Spravato is administered as a nasal spray under the supervision of a healthcare provider in a certified medical office or clinic. The initial phase of treatment typically involves twice-weekly dosing, which may be reduced over time based on the patient’s response.

  • If you have treatment-resistant depression and have not found relief with other antidepressants, Spravato might be a suitable option. Consult with a healthcare provider who can assess your medical history, current condition, and overall suitability for this treatment.

Research Center

Acacia Team